Skip to main content

BARCLAYS PLC

Position in SMMT — Summit Therapeutics Inc.

CIK 312069 LONDON, X0

Position in SMMT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$930,992
-$4,987,448 QoQ
Shares Held
49,103
-85.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,145,056 across 362 Biotechnology names. SMMT ranks #107 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SMMT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $930,992 49,103
2025-12-31 $5,918,440 338,390
2025-09-30 $9,829,552 475,777
2025-06-30 $6,678,173 313,824
2025-03-31 $4,930,754 255,612
2024-12-31 $5,891,454 330,146
2024-09-30 $5,477,583 250,118
2024-06-30 $3,021,041 387,313
2024-03-31 $1,628,311 393,312
2023-12-31 $831,454 318,565
2023-09-30 $276,789 148,016
2023-06-30 $121,161 48,272
2023-03-31 $431,311 246,464
2022-12-31 $58,900 13,859
2022-09-30 $2,485 2,089
2022-06-30 $1,128 1,128
2022-03-31 $10,683 4,361